Trial design challenges when <font color="red">combining_1</font> <font color="red">medication_1</font> <font color="red">and_1</font> <font color="red">parent_1</font> <font color="red">training_1</font> in children with <font color="red">pervasive_1</font> <font color="red">developmental_1</font> <font color="red">disorders_1</font> <font color="red">._1</font> <font color="red">
<br>
<br>_1</font> This paper presents the rationale for a 24-week , randomized trial designed to test whether risperidone plus structured parent training would be superior to risperidone only on measures of <font color="red">noncompliance_3</font> <font color="red">,_3</font> <font color="red">irritability_3</font> <font color="red">and_3</font> <font color="red">adaptive_3</font> <font color="red">functioning_3</font> <font color="red">._3</font> In this model , <font color="red">medication_2</font> <font color="red">reduces_3</font> <font color="red">tantrums_5</font> <font color="red">,_5</font> <font color="red">aggression_5</font> <font color="red">and_5</font> <font color="red">self_5</font> <font color="red">-_5</font> <font color="red">injury_5</font> <font color="red">;_5</font> <font color="red">parent_1</font> <font color="red">training_1</font> <font color="red">promotes_3</font> <font color="red">improvement_4</font> <font color="red">in_4</font> <font color="red">noncompliance_5</font> <font color="red">and_5</font> <font color="red">adaptive_5</font> <font color="red">functioning_5</font> <font color="red">._5</font> Thus , <font color="red">medication_1</font> <font color="red">and_1</font> <font color="red">parent_1</font> <font color="red">training_1</font> <font color="red">target_1</font> <font color="red">related_1</font> <font color="red">,_1</font> <font color="red">but_1</font> <font color="red">separate_1</font> <font color="red">,_1</font> <font color="red">outcomes_1</font> <font color="red">._1</font> At week 24 , the medication was gradually withdrawn to determine whether subjects in the combined treatment group could be managed on a lower dose or off <font color="red">medication_1</font> <font color="red">without_1</font> <font color="red">relapse_2</font> <font color="red">._2</font> Both <font color="red">symptom_5</font> <font color="red">reduction_5</font> <font color="red">and_4</font> <font color="red">functional_5</font> <font color="red">improvement_5</font> are important clinical treatment targets . Thus , experimental evidence on the beneficial effects of <font color="red">combining_1</font> <font color="red">pharmacotherapy_1</font> <font color="red">and_1</font> <font color="red">exportable_1</font> <font color="red">behavioral_1</font> <font color="red">interventions_1</font> is needed to guide clinical practice .